Notícias Spero Therapeutics Inc - SPRO | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Spero Therapeutics Inc (SPRO)
Spero Therapeutics Inc (SPRO) Notícias

Spero Therapeutics Inc (SPRO)

0,8294

0,0144

( 1,77% )

Atualizado: 15:43:13

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

Form 4 - Statement of changes in beneficial ownership of securities

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

Form 8-K - Current report

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

Form 8-K - Current report

Spero Therapeutics to Present at Upcoming September Investor Conferences

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Spero Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições